Skip to main content
. 2022 Jul 1;144(3):413–435. doi: 10.1007/s00401-022-02450-3

Fig. 7.

Fig. 7

Paradigm of proposed NOVA1 pathological changes and functional aberrations during early and late stages of ALS disease course as determined by TDP-43 pathology. Altered cellular and functional properties of NOVA1 are specifically present at early stages of ALS